| P50 | author | Shantanu Bandyopadhyay | Q82077039 |
| | Sarwar Beg | Q82172093 |
| P2093 | author name string | Bhupinder Singh | |
| | O P Katare | |
| | Sumant Saini | |
| P2860 | cites work | Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin | Q39858356 |
| | Quality by design I: Application of failure mode effect analysis (FMEA) and Plackett-Burman design of experiments in the identification of "main factors" in the formulation and process design space for roller-compacted ciprofloxacin hydrochloride im | Q42068504 |
| | Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity | Q46598139 |
| | Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery | Q49058125 |
| | Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLC. | Q52931666 |
| | Development and Validation of a Stability-Indicating Liquid Chromatographic Method for Estimating Olmesartan Medoxomil Using Quality by Design. | Q53639158 |
| | Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability | Q33578636 |
| | Preparation and enhanced oral bioavailability of cryptotanshinone-loaded solid lipid nanoparticles | Q33986082 |
| | Potential of solid lipid nanoparticles in brain targeting | Q34010210 |
| | Olmesartan medoxomil | Q34698761 |
| | Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations | Q35013521 |
| | Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies | Q35684362 |
| | Approaches to oral drug delivery for challenging molecules | Q36585267 |
| | Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: Design and in vivo study | Q36870135 |
| | When poor solubility becomes an issue: from early stage to proof of concept | Q36872588 |
| | Design and optimization of self-nanoemulsifying drug delivery systems for improved bioavailability of cyclovirobuxine D | Q37066732 |
| | Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products | Q37320828 |
| | Considerations in Developing a Target Product Profile for Parenteral Pharmaceutical Products | Q37788992 |
| | Bioavailability enhancement strategies: basics, formulation approaches and regulatory considerations | Q37921818 |
| | From innovative polymers to advanced nanomedicine: key challenges, recent progress and future perspectives: the second Symposium on Innovative Polymers for Controlled Delivery Suzhou, China, 11–14 September 2012 . | Q39470513 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | statistics | Q12483 |
| | multivariate statistics | Q1952580 |
| P304 | page(s) | 407-420 | |
| P577 | publication date | 2017-11-08 | |
| P1433 | published in | Drug Development and Industrial Pharmacy | Q5308840 |
| P1476 | title | QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques | |
| P478 | volume | 44 | |